Navigation Links
MAP Pharmaceuticals Reports First Quarter of 2011 Financial Results
Date:5/3/2011

MOUNTAIN VIEW, Calif., May 3, 2011 /PRNewswire/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced financial results for the first quarter ended March 31, 2011.

The net income for the first quarter ended March 31, 2011 was $17.6 million compared to a net loss of $14.1 million during the same period in 2010. Net income for the first quarter ended March 31, 2011 was related primarily to the $34.2 million in collaboration revenue recognized from a $60.0 million upfront payment received in February 2011 pursuant to a collaboration agreement with Allergan, Inc., compared to no collaboration revenue for the first quarter ended March 31, 2010.

MAP Pharmaceuticals had $114.8 million in cash and cash equivalents as of March 31, 2011, compared to $76.0 million as of December 31, 2010.

"We began 2011 by securing a strategic collaboration with Allergan for LEVADEX®, our investigational drug for the acute treatment of migraine. The companies have been working closely together as MAP Pharmaceuticals prepares to submit its New Drug Application (NDA) to the U.S. Food and Drug Administration in the first half of 2011, while also building infrastructure and strategy for the launch and commercialization of LEVADEX, if approved," said Timothy S. Nelson, president and chief executive officer of MAP Pharmaceuticals. "In addition, we continue to present scientific data on LEVADEX, most recently at the 63rd Annual Meeting of the American Academy of Neurology. In our pharmacodynamics study there was no difference in pulmonary arterial systolic pressure between the LEVADEX and the placebo group over two hours and in our pharmacokinetics study comparing smokers vs. non-smokers, LEVADEX exposure was not higher in smokers."

Revenues for the first quarter ended March 31, 2011 were $34.2 million compared to $0 for the same period in 2010. In February 2011, pursuan
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
2. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
3. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
4. ADVENTRX Pharmaceuticals to Report Second Quarter 2008 Results
5. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121, an ErbB3 Antagonist
6. VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference
7. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
8. Access Pharmaceuticals to Present at the Noble Financial Equity Conference
9. Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)
10. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
11. Lotus Pharmaceuticals Announces Second Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... Republic (PRWEB) May 25, 2013 Significant ... optical manipulation have been recognized with presentation of ... The presentations were made 16 April during the SPIE ... the international society for optics and photonics , is ... Perina of Palacký University was presented with the 2011 ...
(Date:5/25/2013)... 25, 2013 Dennis R. HIll M.D. Radiation ... CA reports that recently there has been a promotion of ... improved the permanent seed, or low dose rate, brachytherapy for ... a higher energy, a shorter half life, and gives a ... that Cesium 131 has a higher average energy than the ...
(Date:5/24/2013)... Dr. Ingrid Warmuth and Anamaria Newport, MHS, ... proud to announce an Open House at their Swedesboro location, ... June 8th from 10 AM to 2 PM. , ... and staff will be on hand to talk to people ... and provide complimentary cosmetic consultations. There will also be specials ...
(Date:5/24/2013)... 2013 In a sneak preview ... will present technologies with applications in multiple and ... SPIE Optics and Photonics symposium in San ... the international society for optics and photonics , ... sciences and technology meeting in North America, with ...
Breaking Biology Technology:ICO Honors Three with Awards during SPIE Optics and Optoelectronics 2ICO Honors Three with Awards during SPIE Optics and Optoelectronics 3Dennis R. Hill MD HDR Prostate Brachytherapy Specialist Compares Prostate Cancer Treatment Options: Not All Low Dose Rate Brachytherapy Isotopes Are the Same 2Dennis R. Hill MD HDR Prostate Brachytherapy Specialist Compares Prostate Cancer Treatment Options: Not All Low Dose Rate Brachytherapy Isotopes Are the Same 3See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 2See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 3See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 4
... 500th patient was supported with the,Berlin Heart EXCOR(R) Pediatric ... the first implantation of the device in 1990. The,patient, ... Memorial,Hospital in Chicago and has been successfully transplanted in ... been diagnosed a few weeks after birth with left,ventricular ...
... ISELIN, N.J., May 28 SyntheMed, Inc. (OTC ... the development and commercialization of anti-adhesion products, announced ... film for the reduction of adhesions following cardiac ... Goods Administration for use in all patients who ...
... Quest Diagnostics scientists will present results of three ... diagnosis and treatment of chronic myeloid leukemia (CML) and ... American Society of Clinical Oncology (ASCO), scheduled for May ... Incorporated (NYSE: DGX ) is the world,s ...
Cached Biology Technology:500th Patient Receives Berlin Heart EXCOR Pediatric Ventricular Assist Device 2SyntheMed Receives Australian Regulatory Approval for REPEL-CV(R) 2Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 2Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 3Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 4Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 5
(Date:5/24/2013)... Studying complex systems like ecosystems can get messy, especially ... big unknowns like climate change. , In a ... Proceedings of the National Academy of Sciences , ... a fundamental assumption at the very heart of a ... To model how climate changes may impact biodiversity, researchers ...
(Date:5/24/2013)... A frequently expressed concern in the ongoing public health ... especially those that are nutrient dense. A new ... Provide Most Nutrients Per Penny," published in the journal ... of the best nutritional values in the produce aisle, ... than most other raw vegetables and delivering one of ...
(Date:5/24/2013)... largest and fastest growing open-access publishers, today announces the ... . , A broad scope journal covering all specialties, ... and interactive web platform for the research community to ... Frontiers, real-time and interactive peer-review enables fast, fair and ... an average of three months from submission to final ...
Breaking Biology News(10 mins):Understanding the past and predicting the future by looking across space and time 2New research shows that potatoes provide one of the best nutritional values per penny 2Frontiers launches new open-access journal in physics 2Frontiers launches new open-access journal in physics 3
... (February 24, 2012) A new study by the ... uses a new scientific methodology for establishing marine protected ... management options from strict no-take zones to areas ... existing information on the country,s climate, along with dependence ...
... Ore. -- (Feb. 24, 2011) -- Neither births nor deaths ... theoretical physicist John J. Toner of the University of Oregon. ... could point to new cancer therapies. Picture any scenario ... cells, cancer cells, fish, and even tiny plastic rods on ...
... have saved an iconic Australian lizard species from death at ... in the March issue of The American Naturalist . ... predators for the arrival of another, says Richard Shine, a ... Cane toads were introduced in Australia in ...
Cached Biology News:Study IDs new marine protected areas in Madagascar 2New theory shows that neither birth nor death stops a flock 2New theory shows that neither birth nor death stops a flock 3Invasive plant protects Australian lizards from invasive toad: Study 2
... lyophilization stabilizer is designed to stabilize ... for long-term storage. There are ... It is a convenient 10 ... and is superior to other traditional ...
... This coating stabilizer is designed ... as antigens and antibodies for immunoassay ... coating molecules during the coating and ... storage. It can also works ...
... TC-3000 is one of the smallest thermal cyclers ... choice of either the 0.5ml (20 samples) or ... , Fast heating and cooling rate of ... and high performance Fast track programming with ...
... anti-freeze environment for enzyme conjugated antibodies and ... viscosity solution at -20C , No ... is convenient , Contains preservatives to ... Protect enzyme conjugates during storage without the ...
Biology Products: